Molecular pathogen detection
Ended Awarded Last action
- Contract number
- 36C24822N0055
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,508,923
Award facts
- Contract value 100% obligated
- $1,508,922.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $99,765 | |
| Funding Only Action | -$267,159 | |
| Supplemental Agreement for work within scope | $199,530 | |
| Supplemental Agreement for work within scope | $247,417 | |
| Original award | $1,229,369 |
About this award
Biofire Diagnostics LLC, a Salt Lake City-based biotechnology company, received a $1.51 million firm fixed-price blanket purchase agreement (BPA) call from the Department of Veterans Affairs' Veterans Integrated Service Network 8 for molecular pathogen detection capabilities. The contract, awarded on October 1, 2021, with an ultimate completion date of September 30, 2022, represents a delivery order against Biofire's existing General Services Administration Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests (FSS-65-VII). This award supports the VA's diagnostic testing infrastructure by providing Biofire's specialized molecular detection solutions, likely including reagents and FilmArray diagnostic systems that enable rapid identification of multiple pathogens from clinical samples. No set-aside designation was applied to this competitive procurement.
This BPA call reflects Biofire Diagnostics' established position as a key federal healthcare supplier, with the company holding multiple significant contract vehicles across the VA system and other federal agencies. The award falls within the company's broader portfolio of firm fixed-price purchase orders and BPA calls that collectively support infectious disease diagnostic capabilities across federal healthcare providers, including respiratory, gastrointestinal, and bloodstream infection testing panels. As a civilian agency procurement, this contract strengthens diagnostic capacity within the VA's healthcare delivery network while leveraging Biofire's proven molecular diagnostic expertise and established supply relationships with federal healthcare systems.
Quick answers
Who was awarded contract 36C24822N0055?
36C24822N0055 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C24822N0055 worth?
The government has obligated $1,508,923 on 36C24822N0055.
Is contract 36C24822N0055 an order under another contract?
Yes. 36C24822N0055 is a BPA call under V797D30085-36C24820A0028, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24822N0055 competed?
The extent of competition for 36C24822N0055 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award